3rd Circ. Backs $1M FBAR Penalty Against Ex-Pharma CEO
A former pharmaceutical CEO faces almost $1 million in penalties for failing to report his Swiss bank accounts after a Third Circuit panel Friday affirmed a lower court ruling that his...To view the full article, register now.
Already a subscriber? Click here to view full article